查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405855

美国磁振造影血管摄影 (MRA) 市场规模、份额、趋势分析报告：按技术、适应症、最终用途和细分市场预测，2023-2030 年

U.S. Magnetic Resonance Angiography Market Size, Share & Trends Analysis Report By Technique (Contrast Enhanced MRA, Non-contrast Enhanced MRA), By Indication, By End-use, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国磁振造影血管摄影 (MRA) 市场成长与趋势：

Grand View Research, Inc最新报告显示，到2030年，美国磁振造影血管摄影（MRA）市场规模预计将达到29.3亿美元，2023年至2030年成像技术年增长率为2.9%。增强人工智慧（AI）在市场中不断成长，预计将在预测期内为市场成长做出贡献。

人工智慧可以帮助检测肿瘤等异常生长。自动检测透过快速报告改善了患者的整体体验。

在美国，大约十分之四的成年人患有至少一种慢性病，约占总人口的 45%。此外，不断增长的老年人口正在增加需要更好诊断的慢性疾病的盛行率，并且对包括磁振造影血管摄影（MRA）在内的诊断影像的需求预计将会增加。在美国，广泛的私人和公共融资措施的存在可能有助于市场成长。 Medicare 承保您的医疗保健提供者为您进行的 MRI 扫描，作为您医疗诊断的一部分。

有些患者会出现恐惧症恐惧症，出于恐惧而避免核磁共振造影系统。飞利浦、西门子和日立主要企业都为患有恐惧症的患者推出了采用开孔设计的设备。此外，这些公司还提供允许患者在设备内获得音讯体验的设备，以帮助他们放鬆并接受测试。与 CT 机不同， 核磁共振造影系统在诊断过程中不使用辐射。因此，未来几年对 MRI 和 MRA 的需求预计将成长。

美国磁振造影血管摄影 (MRA) 市场报告亮点

  • 从技术造影MRA 在 2022 年的销售中占据主导地位，因为它被认为对孕妇和肾病患者来说是更安全的选择。
  • 造影MRA 片段预计将在预测期内创下最快的复合年增长率，因为它提供了血管与其周围组织和器官相比的详细图像。
  • 腹部 MRA 领域预计 2023 年至 2030 年将创下最高复合年增长率。腹部 MRA 可帮助评估和诊断各种血管异常，检查淋巴结、血管和血流，并确定肿胀和疼痛的原因。
  • 按最终用途划分，由于对负担得起的诊断服务的需求不断增长，医院细分市场在 2022 年的收益方面占据主导地位。预计 2023 年至 2030 年，影像中心领域的复合年增长率将达到最快。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章美国磁振造影血管摄影 (MRA) 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 美国磁振造影血管摄影（MRA）市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国磁振造影血管摄影（MRA）市场：技术评估与趋势分析

  • 美国磁振造影血管摄影 (MRA) 市场：重点
  • 美国磁振造影血管摄影 (MRA) 市场：2022 年和 2030 年技术趋势和市场占有率分析
  • 造影造影血管摄影
  • 非造影MRA

第五章美国磁振造影血管摄影（MRA）市场：适应症估计与趋势分析

  • 美国磁振造影血管摄影 (MRA) 市场：重点
  • 美国磁振造影血管摄影 (MRA) 市场：2022 年和 2030 年适应症趋势和市场占有率分析
  • 腹部
  • 下肢
  • 其他的

第六章美国磁振造影血管摄影（MRA）市场：最终用途估计与趋势分析

  • 美国磁振造影血管摄影 (MRA) 市场：重点
  • 美国磁振造影血管摄影 (MRA) 市场：2022 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
  • 形像中心
  • 门诊手术中心及其他医疗机构

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • GE Healthcare
    • Koninklijke Philips NV
    • Siemens Healthcare GmbH
    • Hitachi, Ltd.
    • Canon, Inc.
    • Shenzhen Anke Hi-Tech Co., Ltd.
    • Time Medical Holding
    • ASG Superconductors SpA
    • Neusoft Corporation
    • Shimadzu Corporation
    • ESAOTE SpA
    • AllTech Medical Systems
    • CentraCare
    • Radiology Associates of Ocala
    • Hunt Regional Healthcare
    • Montgomery Radiology Associates
Product Code: GVR-4-68038-769-8

U.S. Magnetic Resonance Angiography Market Growth & Trends:

The U.S. magnetic resonance angiography market size is expected to reach USD 2.93 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 2.9% from 2023 to 2030 Rising adoption of artificial intelligence (AI) based imaging techniques is expected to contribute to market growth over the forecast period. AI can assist in the detection of abnormal growths, such as tumors. Automatic detection improves the overall patient experience due to faster reporting.

In U.S., around four in ten adults suffer from at least one chronic disease, accounting for around 45% of the total population. Moreover, growing elderly population has given rise to a higher incidence rate of chronic diseases needing better diagnosis, which is anticipated to drive the demand for diagnostic imaging procedures, including magnetic resonance angiography (MRA), in the country. The presence of extensive private and public funding initiatives in U.S. is likely to contribute to market growth. Medicare covers MRI scans ordered by healthcare providers as part of a medical diagnosis.

Some of the patients experience anxiety due to claustrophobia and avoid MRI machines due to fear. Key players such as Philips, Siemens, and Hitachi have launched open bore designs for patients suffering from fear of enclosed spaces. In addition, these companies are offering devices with an audiovisual experience inside the machine to help patients relax while undergoing the procedures. MRI machines use no radiations while diagnosis, unlike CT machines. Hence, demand for MRI and MRA procedures is expected to grow over the coming years.

U.S. Magnetic Resonance Angiography Market Report Highlights:

  • By technique, the non-contrast enhanced magnetic resonance angiography segment dominated the market in 2022 in terms of revenue as it is considered to be a safer alternative for patients who are pregnant or are suffering from kidney disorders
  • The contrast enhanced MRA segment is expected to register the fastest CAGR over the forecast period as they offer a detailed image of the blood vessels as compared to the tissues or organs surrounding them
  • The abdominal MRAs segment is expected to register a maximum CAGR from 2023 to 2030. Abdominal MRAs assist in the assessment and diagnosis of various vascular abnormalities and are performed for the examination of the lymph nodes, blood vessels, blood flow, and to investigate the cause of swelling or pain
  • By end use, the hospitals segment dominated the market in 2022 in terms of revenue on account of increased demand for affordable diagnostic services. The imaging centers segment is expected to register the fastest CAGR from 2023 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technique
    • 1.1.2. Indication
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technique outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Magnetic Resonance Angiography Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. U.S. Magnetic Resonance Angiography Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. U.S. Magnetic Resonance Angiography Market: Technique Estimates & Trend Analysis

  • 4.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 4.2. U.S. Magnetic Resonance Angiography Market: Technique Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Contrast-Enhanced MRA
    • 4.3.1. Contrast-Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Non-contrast Enhanced MRA
    • 4.4.1. Non-contrast Enhanced MRA market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Magnetic Resonance Angiography Market: Indication Estimates & Trend Analysis

  • 5.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 5.2. U.S. Magnetic Resonance Angiography Market: Indication Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Abdomen
    • 5.3.1. Abdomen market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lower Extremities
    • 5.4.1. Lower extremities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Magnetic Resonance Angiography Market: End-use Estimates & Trend Analysis

  • 6.1. U.S. Magnetic Resonance Angiography Market: Key Takeaways
  • 6.2. U.S. Magnetic Resonance Angiography Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Imaging Centers
    • 6.4.1. Imaging centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers and Other Healthcare Settings
    • 6.5.1. Ambulatory Surgical Centers and Other Healthcare Settings market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. GE Healthcare
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Koninklijke Philips N.V.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Siemens Healthcare GmbH
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Hitachi, Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Canon, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Shenzhen Anke Hi-Tech Co., Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Time Medical Holding
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ASG Superconductors SpA
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Neusoft Corporation
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Shimadzu Corporation
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. ESAOTE SpA
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. AllTech Medical Systems
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. CentraCare
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Radiology Associates of Ocala
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Hunt Regional Healthcare
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Montgomery Radiology Associates
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. magnetic resonance angiography market, by technique, 2018 - 2030 (USD Million)
  • Table 3 U.S. magnetic resonance angiography market, by indication, 2018 - 2030 (USD Million)
  • Table 4 U.S. magnetic resonance angiography market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. magnetic resonance angiography: market outlook
  • Fig. 9 U.S. Magnetic Resonance Angiography Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Magnetic Resonance Angiography Market Driver Impact
  • Fig. 15 U.S. magnetic resonance angiography market restraint impact
  • Fig. 16 U.S. Magnetic Resonance Angiography Market Strategic Initiatives Analysis
  • Fig. 17 U.S. magnetic resonance angiography market: Technique movement analysis
  • Fig. 18 U.S. magnetic resonance angiography market: Technique outlook and key takeaways
  • Fig. 19 Contrast enhanced MRA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Non-contrast enhanced MRA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. magnetic resonance angiography market: Indication movement analysis
  • Fig. 22 U.S. magnetic resonance angiography market: Indication outlook and key takeaways
  • Fig. 23 Abdomen market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lower extremities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. magnetic resonance angiography market: End-use movement analysis
  • Fig. 27 U.S. magnetic resonance angiography market: End-use outlook and key takeaways
  • Fig. 28 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Imaging centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Ambulatory surgical centers & other healthcare settings market estimates and forecasts, 2018 - 2030 (USD Million)